ATAI Stock Surges 60% on Eli Lilly Takeover Talks, VC Eyes $9-$11 Price With 105% Upside

According to venture capitalist Magnus Sigurdsson, ATAI stock surged nearly 60% late Wednesday (July 16) after reports of Eli Lilly takeover talks. Sigurdsson, co-founder of Systematic Ventures, estimated a likely acquisition price of $9 to $11 per share, with the top end representing a 105% upside from the last close. He noted that the negotiations likely center on valuation and risk-sharing, with a competing bid unlikely given the formal sale process.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments